Kenneth W. O'Keefe, Director at Jazz Pharmaceuticals plc (JAZZ), sold 400,000 shares at $58.28 ($23.3M) on 2013-03-08, disclosed to the SEC on 2013-03-12.
Open-market sale of $23.3M JAZZ by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| JAZZ | SELL | 2022-08-09 | $332K | — | Filing → |
| JAZZ | SELL | 2021-08-10 | $386K | — | Filing → |
| JAZZ | SELL | 2020-11-09 | $3.4M | — | Filing → |